WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005011652) USE OF A VITAMIN D RECEPTOR ACTIVATOR OR A VITAMIN D ANALOG TO TREAT KIDNEY DISEASE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/011652    International Application No.:    PCT/US2004/024517
Publication Date: 10.02.2005 International Filing Date: 29.07.2004
IPC:
A61K 9/00 (2006.01), A61K 9/70 (2006.01), A61K 31/401 (2006.01), A61K 31/59 (2006.01), A61K 31/592 (2006.01), A61K 31/593 (2006.01), A61K 45/06 (2006.01)
Applicants: ABBOTT LABORATORIES [US/US]; Dept. 377 Bldg AP6A-1, 100 Abbott Park Road, Abbott Park, IL 60064-6008 (US) (For All Designated States Except US).
MELNICK, Joel [US/US]; (US) (For US Only).
TIAN, Jin [US/US]; (US) (For US Only).
WILLIAMS, Laura [US/US]; (US) (For US Only).
DELGADO-HERRERA, Leticia [US/US]; (US) (For US Only)
Inventors: MELNICK, Joel; (US).
TIAN, Jin; (US).
WILLIAMS, Laura; (US).
DELGADO-HERRERA, Leticia; (US)
Agent: COLEMAN-JAMES, Patricia; Dept. 377 Bldg AP6A-1, 100 Abbott Park Road, Abbott Park, IL 60064-6008 (US)
Priority Data:
60/491,025 29.07.2003 US
Title (EN) USE OF A VITAMIN D RECEPTOR ACTIVATOR OR A VITAMIN D ANALOG TO TREAT KIDNEY DISEASE
(FR) UTILISATION DE VITAMINES D POUR LE TRAITEMENT DE MALADIE RÉNALE
Abstract: front page image
(EN)The present invention relates to the use of Vitamin D receptor activator or Vitamin D analog, preferably paricalcitol, to treat, prevent and delay progression of kidney dissease. According to one embodiment, the compounds are provided in a sustained release pharmaceutical composition. According to another embodiment, the Vitamin D receptor activator or Vitamin D analog is combined with at least one of an angiotensin converting enzyme inhibitor, an angiotensin (II) receptor (I) blocker or an aldosterone blocker.
(FR)La présente invention a trait à l'utilisation de la vitamine D ou un analogue de la vitamine D, de préférence le paricalcitol, pour le traitement, la prévention et le retardement de maladie rénale.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)